Article
A critical role for PLCG1 in RAS activation by BCR-ABL1 and FLT3-ITD
2023-04-10
Abstract excerpt
Myeloid leukemias are frequently associated with pathologically activating mutations in tyrosine kinases [BCR-ABL1 in chronic myeloid leukemia (CML); FLT3 juxtamembrane internal tandem duplication (ITD) mutations, FLT3 and KIT activation loop mutations in acute myeloid leukemia (AML)]. Mutations in these kinases activate RAS, which initiates multiple downstream signaling pathways that regulate cell proliferation,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 93496518-0add-534a-a24d-e791ffe639d3
- DOI
- 10.1101/2023.04.07.536070
